3M · Earnings release · 8-K Exhibit 99

3M Reports Fourth-Quarter and Full-Year 2025 Results; Initiates Full-Year 2026 Financial Guidance

•Q4 GAAP sales of $6.1 billion, up 2.1%; operating margin of 13.0%, down 510 bps; EPS of $1.07, down 20%, all YoY

◦Adjusted sales of $6.0 billion with organic growth of 2.2% YoY

◦Adjusted operating margin of 21.1%, up 140 bps YoY

◦Adjusted EPS of $1.83, up 9% YoY

•Q4 operating cash flow of $1.6 billion with adjusted free cash flow of $1.3 billion

•Full-year GAAP sales of $24.9 billion, up 1.5%; operating margin of 18.6%, down 100 bps; EPS of $6.00, down 17%, all YoY

◦Adjusted sales of $24.3 billion with organic growth of 2.1% YoY

◦Adjusted operating margin of 23.4%, up 200 bps YoY

◦Adjusted EPS of $8.06, up 10% YoY

•Full-year operating cash flow of $2.3 billion with adjusted free cash flow of $4.4 billion

ST. PAUL, Minn. – Jan. 20, 2026 − 3M (NYSE: MMM) today reported fourth-quarter and full-year 2025 results.

“2025 was an important year for 3M as we build a strong foundation that is reshaping our operating model and driving sustainable value creation,” said William Brown, 3M Chairman and CEO. “I want to thank the team for their dedication to eXcellence, which helped us finish 2025 with growth above macro, strong margin expansion, double-digit earnings growth, and solid cash conversion. Our accelerated pace of innovation and commercial execution positions us to outperform the macro environment again in 2026. T1Our continued operating rigor supports further margin expansion and earnings growth, putting us on a clear path to meet or exceed the 2027 financial commitments we outlined at our Investor Day last year.”

Fourth-quarter highlights:

GAAP EPS from continuing operations (GAAP EPS)

$

$

Special items:

Net costs for significant litigation

(Increase) decrease in value of Solventum ownership

Pension risk transfer charge

—

Manufactured PFAS products

Transformation costs

—

Adjusted EPS from continuing operations (adjusted EPS)

$

$

Memo:

GAAP operating income margin

%

%

Adjusted operating income margin

%

%

•GAAP EPS of $1.07 and operating margin of 13.0%.

•Adjusted EPS of $1.83, up 9% year-on-year.

•Adjusted operating income margin of 21.1%, an increase of 140 basis points year-on-year.

GAAP

Adjusted (non-GAAP)

Net sales (billions)

Sales change

Total sales

Components of sales change:

Organic sales

Acquisitions/divestitures

Translation

Adjusted sales excludes manufactured PFAS products.

•Sales of $6.1 billion, up 2.1% year-on-year with organic sales up 0.6% year-on-year.

•Adjusted sales of $6.0 billion, up 3.7% year-on-year with adjusted organic sales up 2.2% year-on-year.

•3M returned $0.9 billion to shareholders via dividends and share repurchases.

•Cash from operations of $1.6 billion.

•Adjusted free cash flow of $1.3 billion.

1

Full-Year highlights:

GAAP EPS

$

$

Special items:

Net costs for significant litigation

(Increase) decrease in value of Solventum ownership

Pension risk transfer charge

—

Manufactured PFAS products

Loss on business divestitures

—

Divestiture costs

—

Transformation costs

—

Adjusted EPS

$

$

Memo:

GAAP operating income margin

%

%

Adjusted operating income margin

%

%

•GAAP EPS of $6.00 and operating margin of 18.6%.

•Adjusted EPS of $8.06, up 10% year-on-year.

•Adjusted operating income margin of 23.4%, an increase of 200 basis points year-on-year.

GAAP

Adjusted (Non-GAAP)

Net sales (billions)

Sales change

Total sales

Components of sales change:

Organic sales

Acquisitions/divestitures

Translation

Adjusted sales excludes manufactured PFAS products.

•Sales of $24.9 billion, up 1.5% year-on-year with organic sales up 0.9% year-on-year.

•Adjusted sales of $24.3 billion, up 2.7% year-on-year with adjusted organic sales up 2.1% year-on-year.

•T23M returned $4.8 billion to shareholders via dividends and share repurchases.

•Cash from operations of $2.3 billion.

•Adjusted free cash flow of $4.4 billion.

This document includes reference to certain non-GAAP measures. See the “Supplemental Financial Information Non-GAAP Measures” section for applicable information.

2

3M provided the following full-year 2026 expectations.

•G1T3Adjusted total sales growth1 of ~4 percent, G2reflecting adjusted organic sales growth1 of ~3 percent.

•G3Adjusted operating income margin expansion1 of 70 bps to 80 bps.

•G5T4Adjusted operating cash flow1 of $5.6 to $5.8 billion, contributing to G6>100 percent adjusted free cash flow conversion1.

1As further discussed at 4 within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.

Conference call

3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:

•Live webcast at https://investors.3M.com

•Webcast replay at https://investors.3m.com/financials/quarterly-earnings

Forward-looking statements

This document contains forward-looking statements. You can identify these statements by the use of words such as “plan,” “expect,” “aim,” “believe,” “project,” “target,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could,” “would,” “forecast,” “future,” “outlook,” “guidance” and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation; recession; military conflicts; T5trade restrictions such as sanctions, tariffs, reciprocal and retaliatory tariffs, and other tariff-related measures; regulatory requirements, legal actions, or enforcement; and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals, known as “PFAS,” including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company’s exit of PFAS manufacturing and work to discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement (“PWS Settlement”) to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to ongoing PFAS-related settlements and claims; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K (Reports), as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way; (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information or operational technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company’s Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; risks under the agreements and obligations entered into in connection with the spin-off; and (16) matters relating to Combat Arms Earplugs (“CAE”) and related products.

A further description of these factors is located in the Reports under “Cautionary Note Concerning Factors That May Affect Future Results” and “Risk Factors” in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

3

3M Company and Subsidiaries

CONSOLIDATED STATEMENT OF INCOME

(Millions, except per-share amounts)

(Unaudited)

Three months ended

Year ended

Net sales

$

$

$

$

Operating expenses

Cost of sales

Selling, general and administrative expenses

Research, development and related expenses

(Gain) loss on business divestitures

(2)

—

—

Total operating expenses

Operating income

Other expense (income), net

3

Income from continuing operations before income taxes

Provision for income taxes

Income from continuing operations of consolidated group

Income from unconsolidated subsidiaries, net of taxes

1

2

9

Net income from continuing operations including noncontrolling interest

Less: net income (loss) attributable to noncontrolling interest

(3)

—

Net income from continuing operations attributable to 3M

Net income from discontinued operations, net of taxes

—

—

—

Net income attributable to 3M

$

$

$

$

Earnings per share attributable to 3M common shareholders:

Weighted average 3M common shares outstanding — basic

Earnings per share from continuing operations — basic

$

$

$

$

Earnings per share from discontinued operations — basic

—

—

—

Earnings per share — basic

$

$

$

$

Weighted average 3M common shares outstanding — diluted

Earnings per share from continuing operations — diluted

$

$

$

$

Earnings per share from discontinued operations — diluted

—

—

—

Earnings per share — diluted

$

$

$

$

4

3M Company and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEET

(Dollars in millions)

(Unaudited)

Assets

Current assets

Cash and cash equivalents

$

$

Marketable securities

Accounts receivable – net

Inventories

Prepaids

Assets held for sale

—

Other current assets

Total current assets

Property, plant and equipment – net

Operating lease right of use assets

Goodwill and intangible assets – net

Other assets

Total assets

$

$

Liabilities and equity

Current liabilities

Short-term borrowings and current portion of long-term debt

$

$

Accounts payable

Accrued payroll

Operating lease liabilities

Liabilities held for sale

—

Other current liabilities

Total current liabilities

Long-term debt

Other liabilities

Total liabilities

Total equity

Shares outstanding

Total liabilities and equity

$

$

5

3M Company and Subsidiaries

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in millions)

(Unaudited)

Year ended December 31,

Net cash provided by (used in) operating activities

$

$

Cash flows from investing activities:

Purchases of property, plant and equipment

Purchases and proceeds from sale or maturities of marketable securities and investments – net

Other investing activities

Net cash provided by (used in) investing activities

Cash flows from financing activities:

Change in debt – net

Purchases of treasury stock and dividends paid to shareholders

Proceeds from issuances of treasury stock pursuant to stock option and benefit plans

Cash transferred to Solventum related to separation, net

—

Other financing activities

Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents

Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale

Less: net increase (decrease) in cash classified within assets held for sale

—

Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents at beginning of year

Cash and cash equivalents at end of period

$

$

The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.

6

3M Company and Subsidiaries

SALES CHANGE ANALYSIS2

(Unaudited)

By reportable business segment

Organic sales

Divestitures

Translation

Total sales

change

Safety and Industrial

%

—

%

%

%

Transportation and Electronics

Consumer

—

Total reportable business segments

Total Company

By geographic area

Americas

%

%

%

%

China

—

Other Asia

—

Europe, Middle East and Africa

—

By reportable business segment

Organic sales

Divestitures

Translation

Total sales

change

Safety and Industrial

%

—

%

%

%

Transportation and Electronics

Consumer

—

Total reportable business segments

—

Total Company

By geographic area

Americas

%

%

%

%

China

Other Asia

—

Europe, Middle East and Africa

2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.

7

3M Company and Subsidiaries

BUSINESS SEGMENTS

(Unaudited)

3M discloses business segment operating income as its measure of segment profit, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Other”).

Three months ended

Year ended

Net sales (millions)

Abrasives

$

$

$

$

Automotive Aftermarket

Electrical Markets

Industrial Adhesives and Tapes

Industrial Specialties Division

Personal Safety

Roofing Granules

Total Safety and Industrial business segment

Advanced Materials

Automotive and Aerospace

Commercial Branding and Transportation

Electronics

Total Transportation and Electronics business segment

Consumer Safety and Well-Being

Home and Auto Care

Home Improvement

Packaging and Expression

Total Consumer business segment

Total reportable business segments

Corporate and Other

Total company

$

$

$

$

Operating income (millions)

Safety and Industrial

$

$

$

$

Transportation and Electronics

Consumer

Total reportable business segments

Corporate and Other

Corporate-level (expense) income

(5)

Corporate special items:

Net costs for significant litigation

Divestiture costs

—

—

—

Gain (loss) on business divestitures

2

—

—

Transformation costs

—

—

Total Corporate and Other

Total company operating income

Other expense/(income), net

3

Income from continuing operations before income taxes

$

$

$

$

8

3M Company and Subsidiaries

BUSINESS SEGMENTS - (CONTINUED)

(Unaudited)

Corporate and Other

Outside of 3M's reportable segments, 3M has Corporate and Other which is not a reportable business segment as it does not meet the segment reporting criteria. Because Corporate and Other includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis.

Corporate and Other operating income (loss) includes:

•Corporate-level (expense) income includes:

◦certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs that 3M may choose not to allocate directly to its business segments,

◦commercial activity with Solventum following its April 1, 2024 Separation and certain operations of the former Health Care business segment retained by 3M,

◦transition arrangement agreements (e.g., fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Solventum Separation,

◦operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with previous divestitures, and

◦costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations.

•Corporate special items include, for the periods presented:

◦T6net costs for significant litigation impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters,

◦gain (loss) on business divestitures,

◦divestiture costs (related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture) that were not eligible to be part of discontinued operations, and

◦transformation program restructuring and related charges.

9

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES

(Unaudited)

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies.

Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Other, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable.

This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:

GAAP amounts for which a measure adjusted for special items is also provided:

Reasons 3M believes the measure is useful:

•Net sales (and sales change)

Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items

•Operating income (loss), total reportable segment operating income, segment operating income (loss) and operating income (loss) margin (and expansion)

•Income from continuing operations before taxes

•Provision for income taxes and effective tax rate

•Net income from continuing operations

•EPS from continuing operations

Additional non-GAAP measures:

•Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion

Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance

The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

Certain amounts adjusted for special items (non-GAAP measures):

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Operating income

Operating income margin

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

(4)

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

$

%

Adjustments for special items:

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

$

%

Total reportable business segments

GAAP amounts

$

$

%

Adjustments for special items:

Net costs for significant litigation

—

(4)

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

$

%

Total company

GAAP amounts

$

$

%

$

$

%

$

$

Adjustments for special items:

Net costs for significant litigation

—

Manufactured PFAS products

Pension risk transfer charge

—

—

3

Solventum ownership - change in value

—

—

—

Total special items

Adjusted amounts (non-GAAP measures)3

$

$

%

$

$

%

$

$

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Sales change

Operating income

Operating income margin

Operating income margin expansion

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

EPS percent change

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

%

$

%

Adjustments for special items:

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

%

$

%

Total reportable business segments

GAAP amounts

$

%

$

%

Adjustments for special items:

Net costs for significant litigation

—

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

%

$

%

Total company

GAAP amounts

$

%

$

%

$

$

%

$

$

%

Adjustments for special items:

Net costs for significant litigation

—

Loss on business divestitures

—

(2)

(2)

—

(2)

—

Manufactured PFAS products

Solventum ownership - change in value

—

—

—

Transformation costs

—

(4)

Total special items

Adjusted amounts (non-GAAP measures)3

$

%

$

%

$

$

%

$

$

9

%

3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Operating income

Operating income margin

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

$

%

Adjustments for special items:

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

$

%

Total reportable business segments

GAAP amounts

$

$

%

Adjustments for special items:

Net costs for significant litigation

—

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

$

%

Total Company

GAAP amounts

$

$

%

$

$

%

$

$

Adjustments for special items:

Net costs for significant litigation

—

Divestiture costs

—

Manufactured PFAS products

Pension risk transfer charge

—

—

Solventum ownership - change in value

—

—

—

Total special items

Adjusted amounts (non-GAAP measures)3

$

$

%

$

$

%

$

$

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Sales change

Operating income

Operating income margin

Operating income margin expansion

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

EPS percent change

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

%

$

%

Adjustments for special items:

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

%

$

%

Total reportable business segments

GAAP amounts

$

%

$

%

Adjustments for special items:

Net costs for significant litigation

—

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

%

$

%

Total Company

GAAP amounts

$

%

$

%

bps

$

$

%

$

$

%

Adjustments for special items:

Net costs for significant litigation

—

9

Loss on business divestitures

—

3

Manufactured PFAS products

Solventum ownership - change in value

—

—

Transformation costs

—

(1)

Total special items

Adjusted amounts (non-GAAP measures)3

$

%

$

%

bps

$

$

%

$

$

%

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

2026 adjusted operating income margin expansion (non-GAAP measure)3,4

2026 adjusted earnings per share from continuing operations (non-GAAP measure)3,4

2026 adjusted effective tax rate (non-GAAP measure)3,4

43M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains (losses); divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; transformation costs; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low.

Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”.

Sales change2

Organic sales

Divestitures

Translation

Total sales change

Total company

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted total company (non-GAAP measures)3

%

%

%

%

Total reportable business segments

%

%

%

%

Remove manufactured PFAS products special item impact

—

Adjusted total reportable business segments (non-GAAP measures)3

%

%

%

%

Transportation and Electronics

%

%

%

%

Remove manufactured PFAS products special item impact

Adjusted Transportation and Electronics (non-GAAP measures)3

%

%

%

%

Sales change2

Organic sales

Divestitures

Translation

Total sales change

Total Company

%

%

%

%

Remove manufactured PFAS products special item impact

—

Adjusted total Company (non-GAAP measures)3

%

%

%

%

Transportation and Electronics

%

—

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Transportation and Electronics (non-GAAP measures)3

%

—

%

%

%

Sales change2

Organic sales

Divestitures

Translation

Total sales change

Total Company

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted total Company (non-GAAP measures)3

%

%

%

%

Transportation and Electronics

%

%

%

%

Remove manufactured PFAS products special item impact

—

Adjusted Transportation and Electronics (non-GAAP measures)3

%

%

%

%

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

Sales change2

Organic sales

Divestitures

Translation

Total sales change

Total Company

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted total Company (non-GAAP measures)3

%

%

%

%

Total reportable business segments

%

—

%

%

%

Remove manufactured PFAS products special item impact

Adjusted total reportable business segments (non-GAAP measures)3

%

%

%

%

Transportation and Electronics

%

%

%

%

Remove manufactured PFAS products special item impact

Adjusted Transportation and Electronics (non-GAAP measures)3

%

%

%

%

By geographic area

Americas

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Americas (non-GAAP measures)3

%

%

%

%

China

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted China (non-GAAP measures)3

%

%

%

%

Other Asia

%

—

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Other Asia (non-GAAP measures)3

%

—

%

%

%

Europe, Middle East & Africa

%

%

%

%

Remove manufactured PFAS products special item impact

—

Adjusted Europe, Middle East & Africa (non-GAAP measures)3

%

%

%

%

By particular country

United States

%

%

—

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted United States (non-GAAP measures)3

%

%

—

%

%

Sales Change2

Organic sales

Acquisitions

Divestitures

Translation

Total sales change

Total Company4

~3%

—

%

—

%

~1%

~4%

Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-GAAP measures):

Three months ended

Year ended

Major GAAP cash flow categories (dollars in millions)

Net cash provided by (used in) operating activities

$

$

$

$

Net cash provided by (used in) investing activities

Net cash provided by (used in) financing activities

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

Three months ended

Year ended

Adjusted free cash flow (non-GAAP measure) (dollars in millions)

Net cash provided by (used in) operating activities

$

$

$

$

Adjustments for special items:

Net costs/(recoveries) for significant litigation after-tax payment impacts

Divestiture costs and divestiture-related restructuring after-tax payment impacts

TCJA transition tax payment

—

—

Transformation actions after-tax payment impacts

—

—

Manufactured PFAS products after-tax payment impacts

Total adjustments for special items